Elsevier is one of the largest, most hated and most influential academic publishing companies in the world. How it started & how it's going A thread🧵

nature.com/articles/s4137… We summarized the evidence on MRD in AML & its role in clinical practice: when & how to use it for guiding therapeutic decisions. 🙏 for my co-authors Amer Zeidan MBBS,MHS ‏عامر زيدان Sanam Loghavi, MD صنم لغوی 🔬🧬 Anthony Perissinotti, & Chris Hourigan for his valuable review Leukemia Journal

Hot off the press… 📣 everything you wanted to know about AML #MRD Congratulations Firas El Chaer, MD, MSHCM #leusm #hemepath

Menin inhibition is a standard of care! FDA approval of revumenib!! So happy to see that the benefit witnessed in patients on study is leading to a medicine to all who need it. Ready to forj ahead with more to come! ;)

#Weekend_review on #menin_inhibitors for treatment of leukemia in light on Revumenib approval (AUGMENT-101) #leusm #AML 🧵 FDA approves revumenib for relapsed or refractory acute leukemia with a KMT2A translocation fda.gov/drugs/resource…

A third year fellowship position in Transplant and Oncology Infectious Diseases is open at UT MD Anderson. Cutting edge cancer care, SCT, and CAR-T MD Anderson Cancer Center and SOT Texas Medical Center. Enjoy working with UTHealth Houston Infectious Diseases, BCM ID Fellowship and Houston Methodist. DM Pablo Okhuysen

Understanding and treating myelofibrosis A short thread on selected clinical abstracts from #ASH24 ASH #mpnsm

A great study! Honored to have contributed to it with UVA Department of Medicine and UVA HemeOnc Fellowship and so many other institutions. #ASH24

CONGRESS | #ASH24 | PRESENTATION Firas El Chaer, MD, MSHCM, UVA, shared findings from an ongoing phase I/II trial (NCT04176198) of nuvisertib monotherapy in patients with R/R MF (N=65). The treatment was well tolerated, with no DLTs reported. Among 18 evaluable patients receiving the

Post-ASH 2024 MPN highlights webinar February 7, 2025 us06web.zoom.us/webinar/regist…

Had a great time ASCO with great friends and colleagues teaching about clinical management of AML. We even got to see ❄️! Thanks for the opportunity! Dr. Catherine Lai Brittany Knick Ragon, MD Firas El Chaer, MD, MSHCM UNC Lineberger

After 5 incredible years at UVA Cancer Center I’m excited to announce that I’m headed to lead the #Leukemia and #MPN Program at Miami Cancer Institute Research. Grateful for all I’ve accomplished alongside amazing colleagues at UVA—looking forward to the new opportunities ahead at MCI!

Key #ASH2024 #MPNs highlights!🇺🇸🩸 📌 #Nuvisertib (TP-3654), an investigational selective PIM1 #kinaseinhibitor, showed durable #clinical response and sustained #hematological improvement in relapsed/refractory #myelofibrosis patients Firas El Chaer, MD, MSHCM 👉 vjhemonc.com/event/post-ash…

To assist multidisciplinary oncology teams with delivery of bispecific antibody therapy, ACCC offers an on-demand CME series using the Project ECHO model. View at hubs.li/Q03j3YV80 Thank you, Murali Janakiram, Firas El Chaer, MD, MSHCM, PER, and PTCE for your support.

CONGRESS | #EHA2025 | PRESENTATION Firas El Chaer Firas El Chaer, MD, MSHCM Miami Cancer Institute Research presented findings from a phase I/II study evaluating nuvisertib monotherapy in patients with relapsed/refractory #myelofibrosis (N = 77). Nuvisertib was well tolerated with no DLTs, with activity

It was a great honor to chair one of the #MPN sessions at #iwmdsmpn25 with pioneers in the field, David Steensma, MD and Claire Harrison Their mentorship, insights, and contributions continue to shape the future of #MPN research and clinical care. Miami Cancer Institute Research Baptist Health

Excited to share a project with The Leukemia & Lymphoma Society—helped revise their official #AML patient education materials. An incredible opportunity to help improve patient understanding and care. A truly rewarding experience! Miami Cancer Institute Research Baptist Health

👉👉👉 Phenomenal Day 1 of our #MPNWorkshop25 led by Ruben A. Mesa, MD & Naveen Pemmaraju, MD !! So thankful 🙏 to all of our team & colleagues for making this making meeting happen! #MPNSM | PedsHemeDoc Sanam Loghavi, MD صنم لغوی 🔬🧬 Ami Patel, MD Andrew Kuykendall MD Prithviraj Bose Andrew Dunbar Aaron Gerds MD, MS Stephen Oh |